| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥1.26B | ¥1.12B | +12.6% |
| Cost of Sales | ¥606M | ¥535M | +13.3% |
| Gross Profit | ¥660M | ¥589M | +12.0% |
| SG&A Expenses | ¥982M | ¥673M | +46.0% |
| Operating Income | ¥-322M | ¥-84M | -283.3% |
| Non-operating Income | ¥4M | ¥8M | -49.2% |
| Non-operating Expenses | ¥5M | ¥2M | +173.0% |
| Ordinary Income | ¥-323M | ¥-77M | -319.5% |
| Profit Before Tax | ¥-321M | ¥-79M | -305.3% |
| Income Tax Expense | ¥-553,000 | ¥2M | -122.6% |
| Net Income | ¥-320M | ¥-82M | -292.5% |
| Net Income Attributable to Owners | ¥-320M | ¥-81M | -295.1% |
| Total Comprehensive Income | ¥-320M | ¥-81M | -295.1% |
| Depreciation & Amortization | ¥27M | ¥4M | +565.4% |
| Interest Expense | ¥3M | ¥1M | +185.9% |
| Basic EPS | ¥-4.25 | ¥-1.38 | -208.0% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥1.31B | ¥1.54B | ¥-233M |
| Cash and Deposits | ¥98M | ¥155M | ¥-57M |
| Accounts Receivable | ¥182M | ¥233M | ¥-52M |
| Inventories | ¥699M | ¥752M | ¥-52M |
| Non-current Assets | ¥1.85B | ¥1.71B | +¥134M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥-182M | ¥-248M | +¥66M |
| Investing Cash Flow | ¥-199M | ¥-432M | +¥233M |
| Financing Cash Flow | ¥324M | ¥573M | ¥-249M |
| Free Cash Flow | ¥-381M | - | - |
| Item | Value |
|---|---|
| Book Value Per Share | ¥32.46 |
| Net Profit Margin | -25.3% |
| Gross Profit Margin | 52.1% |
| Current Ratio | 292.9% |
| Quick Ratio | 136.2% |
| Debt-to-Equity Ratio | 0.26x |
| Interest Coverage Ratio | -93.01x |
| EBITDA Margin | -23.3% |
| Effective Tax Rate | 0.2% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +12.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 76.79M shares |
| Average Shares Outstanding | 75.28M shares |
| Book Value Per Share | ¥32.62 |
| EBITDA | ¥-295M |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥0.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| AITechnology | ¥22M | ¥-67M |
| BeautyAndWellness | ¥429M | ¥-39M |
| Cosmetics | ¥539M | ¥-84M |
| Investment | ¥20M | ¥18M |
| MarketExpansion | ¥1M | ¥-21M |
| RegenerativeMedicineRelated | ¥258M | ¥-26M |
| Sustainable | ¥919,000 |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥2.84B |
| Operating Income Forecast | ¥-483M |
| Ordinary Income Forecast | ¥-495M |
| Net Income Attributable to Owners Forecast | ¥-499M |
| Basic EPS Forecast | ¥-6.57 |
| Dividend Per Share Forecast | ¥0.00 |
| Property, Plant & Equipment | ¥1.58B | ¥1.42B | +¥155M |
| Intangible Assets | ¥217M | ¥247M | ¥-30M |
| Goodwill | ¥209M | ¥241M | ¥-32M |
| Total Assets | ¥3.15B | ¥3.25B | ¥-99M |
| Current Liabilities | ¥446M | ¥558M | ¥-111M |
| Accounts Payable | ¥122M | ¥182M | ¥-60M |
| Short-term Loans | ¥95M | ¥95M | ¥0 |
| Non-current Liabilities | ¥201M | ¥220M | ¥-19M |
| Long-term Loans | ¥140M | ¥157M | ¥-16M |
| Total Liabilities | ¥647M | ¥777M | ¥-130M |
| Total Equity | ¥2.50B | ¥2.47B | +¥31M |
| Capital Stock | ¥2.03B | ¥1.85B | +¥178M |
| Capital Surplus | ¥3.09B | ¥2.91B | +¥178M |
| Retained Earnings | ¥-2.63B | ¥-2.31B | ¥-320M |
| Owners' Equity | ¥2.49B | ¥2.46B | +¥36M |
| Working Capital | ¥861M | - | - |
| ¥-30M |